Relapse rates and associated risk factors following omalizumab treatment in adolescents with chronic spontaneous urticaria
Year: 2025
Type: article
Study design: Observational Study
Source: Pediatric Allergy and Immunology
DOI: 10.1111/pai.70216
Institution: Hacettepe University
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4414748507
